TA
ACAD icon

Teachers Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Teachers Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$21.6M Buy
803,819
+548,509
+215% +$12.8M 0.03% 623
2018
Q4 		$4.13M Buy
255,310
+4,904
+2% +$95.2K 0.01% 1420
2018
Q3 		$5.2M Buy
250,406
+7,358
+3% +$116K 0.01% 1425
2018
Q2 		$3.71M Sell
243,048
-381,424
-61% -$6.8M ﹤0.01% 1585
2018
Q1 		$14M Buy
624,472
+19,521
+3% +$540K 0.02% 893
2017
Q4 		$18.2M Buy
604,951
+47,361
+8% +$1.51M 0.02% 766
2017
Q3 		$21M Buy
557,590
+401,818
+258% +$13.1M 0.03% 668
2017
Q2 		$4.34M Buy
155,772
+30,750
+25% +$916K 0.01% 1396
2017
Q1 		$4.3M Buy
125,022
+2,722
+2% +$96.1K 0.01% 1374
2016
Q4 		$3.53M Buy
122,300
+16,099
+15% +$426K 0.01% 1459
2016
Q3 		$3.38M Sell
106,201
-1,037
-1% -$35.2K 0.01% 1420
2016
Q2 		$3.48M Sell
107,238
-255,606
-70% -$8.55M 0.01% 1346
2016
Q1 		$10.1M Buy
362,844
+10,980
+3% +$239K 0.02% 853
2015
Q4 		$12.5M Buy
351,864
+1,853
+0.5% +$65.3K 0.02% 762
2015
Q3 		$11.6M Sell
350,011
-14,827
-4% -$617K 0.02% 789
2015
Q2 		$15.3M Buy
364,838
+9,035
+3% +$350K 0.03% 689
2015
Q1 		$11.6M Buy
355,803
+1,525
+0.4% +$52.4K 0.02% 827
2014
Q4 		$11.2M Sell
354,278
-320
-0.1% -$9.07K 0.02% 833
2014
Q3 		$8.78M Hold
354,598
– – 0.02% 922
2014
Q2 		$8.01M Sell
354,598
-3,093
-0.9% -$64.6K 0.02% 951
2014
Q1 		$8.7M Buy
357,691
+34,080
+11% +$862K 0.02% 877
2013
Q4 		$8.09M Buy
323,611
+226,410
+233% +$5.34M 0.02% 907
2013
Q3 		$2.67M Buy
97,201
+4,554
+5% +$95.2K 0.01% 1309
2013
Q2 		$1.68M Buy
+92,647
New +$1.28M ﹤0.01% 1522

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Teachers Advisors's ACAD Position: Q1 2019 in Review

Teachers Advisors increased its Acadia Pharmaceuticals (ACAD) stake by 215% in Q1 2019, buying an estimated $12.8M and bringing the position to 803,819 shares worth $21.6M. The position accounts for 0.03% of the portfolio, ranked #623.

Teachers Advisors first reported a position in ACAD in Q2 2013 and has held it in 24 quarters since. 199 funds tracked by Wall St. Rank hold ACAD as of Q1 2019.

  • Teachers Advisors held 803,819 shares of Acadia Pharmaceuticals worth $21.6M as of Q1 2019.
  • Teachers Advisors bought 548,509 Acadia Pharmaceuticals shares in Q1 2019, an estimated $12.8M.
  • Acadia Pharmaceuticals made up 0.03% of Teachers Advisors's portfolio in Q1 2019, its #623 holding.
  • Teachers Advisors first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • 199 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.